Oral Arsenic (ATO)

arsenic trioxide

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral Arsenic (ATO), covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS) [Phase 1]